Education
About Us
Working with TipRanks
Follow Us
Nils Bottler Insider Profile
4 Followers
Nils Bottler, Director at Bright Minds Biosciences, holds 0.00 shares in Bright Minds Biosciences (Ticker: TSE:DRUG). Most recently, Nils Bottler Sold C$5,000 shares of Bright Minds Biosciences on Mar 07, 2025 for an estimated value of 180.99K.
Nils Bottler Bright Minds Biosciences (DRUG)Director
Bright Minds Biosciences (DRUG)
Director
Ranked #17,911 out of 100,956 Corporate Insiders
Profitable Transactions
5 out of 6 Profitable Transactions
Average Return
+14.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Nils Bottler does not currently own shares as a corporate insider.
A breakdown of Nils Bottler's holdings
Insider Roles
Director
Roles that Nils Bottler holds in companies
Most Profitable Insider Trade
The most profitable trade made by Nils Bottler
Nils Bottler's Trading History
List of latest transactions for each holding click on a transaction to see Nils Bottler's performance on stock
You May Also Like
Nils Bottler insider profile FAQ
What is the percentage of profitable transactions made by Nils Bottler?
The percentage of profitable transactions made by Nils Bottler is 83%.
What is the average return per transaction made by Nils Bottler?
The average return per transaction made by Nils Bottler is 14.20%.
What stocks does Nils Bottler hold?
Nils Bottler holds: TSE:DRUG stocks.
What was Nils Bottler’s latest transaction?
Nils Bottler latest transaction was an Informative Sell of C$180.99K.
What was Nils Bottler's most profitable transaction?
Nils Bottler’s most profitable transaction was an Informative Sell of TSE:DRUG stock on November 2, 2024. The return on the trade was 21.80%.
What is Nils Bottler's role in Bright Minds Biosciences?
Nils Bottler's role in Bright Minds Biosciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.